Page last updated: 2024-08-21

1,1'-methylenedi-2-naphthol and Alzheimer Disease

1,1'-methylenedi-2-naphthol has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrahim, A; Auff, E; Bauer, M; Brunner, M; Carminati, P; Corrado, ME; Dal-Bianco, P; Dudczak, R; Forloni, G; Ghirardi, O; Hofmann, A; Joukhadar, C; Karch, R; Kletter, K; Langer, O; Lanzenberger, R; Lods, N; Müller, M; Piovesan, P	1

Trials

1 trial(s) available for 1,1'-methylenedi-2-naphthol and Alzheimer Disease

Article	Year
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:3 Topics: Adult; Aged; Alzheimer Disease; Amyloid; Area Under Curve; Biological Availability; Blood-Brain Barrier; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Molecular Structure; Naphthols; Neuroprotective Agents; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution	2006

Article

Year

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.

Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:3

Topics: Adult; Aged; Alzheimer Disease; Amyloid; Area Under Curve; Biological Availability; Blood-Brain Barrier; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Molecular Structure; Naphthols; Neuroprotective Agents; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution

2006